市場調查報告書
商品編碼
1384652
全球支氣管鏡市場規模、佔有率、產業趨勢分析報告:2023-2030 年依類型、應用、最終用途、地區分類的展望與預測Global Bronchoscopes Market Size, Share & Industry Trends Analysis Report By Type (Flexible (Video, Fiberoptic, Hybrid), and Rigid), By Usage, By End Use (Hospitals, and Outpatient Facilities), By Regional Outlook and Forecast, 2023 - 2030 |
到 2030 年,支氣管鏡市場規模預計將達到 44 億美元,預測期內複合年成長率為 6.9%。 2022年市場規模為1,308,100台,成長率為9.6%(2019-2022年)。
根據 KBV 基數矩陣中的分析,強生公司是該市場的領導者。美敦力公司、富士軟片控股公司和奧林巴斯公司等公司是市場上的主要創新者。 2022年7月,美敦力宣布推出Illumicite,這是一個用於支氣管鏡手術的系統。該系統具有多種優勢,包括微創設備、更好地觀察組織異常情況以及擴大對病變的接觸範圍。
COVID-19 影響分析
呼吸系統是受 COVID-19 影響最嚴重的系統,促使對支氣管鏡和其他呼吸診斷工具的需求激增。醫院和醫療機構需要支氣管鏡檢查來診斷和治療 COVID-19 患者,特別是那些有嚴重呼吸道症狀的患者。許多醫療機構必須重新分配資源並優先考慮與 COVID-19 相關的護理和設備。此次疫情加速了醫療保健領域的研發,包括新醫療設備和技術的開發。結果,支氣管鏡的設計和功能發生了革命性的變化。感染控制已成為醫療機構的首要任務。製造商和醫療保健提供者加強了支氣管鏡滅菌和清洗方案,以降低交叉污染的風險。因此,COVID-19的爆發對市場產生了溫和的影響。
市場成長要素
呼吸道疾病增加
肺癌、慢性阻塞性肺病(COPD)、氣喘和肺炎等呼吸系統疾病的盛行率不斷增加,推動了對支氣管鏡檢查診斷和治療的需求。肺癌是全球癌症相關死亡的主要原因之一。診斷、分期和治療計劃通常需要支氣管鏡手術。透過支氣管鏡檢查進行早期發現和準確診斷對於提高存活率至關重要。 COPD 是一種包括慢性支氣管炎和肺氣腫的疾病。支氣管鏡檢查可評估氣道發炎,採集組織樣本進行診斷,並提供治療性介入來控制症狀和改善肺功能。呼吸系統疾病盛行率的上升是市場成長的關鍵驅動力。
擴大遠端醫療和遠距會診的採用
遠端醫療和遠距醫療保健服務的發展擴大了支氣管鏡檢查治療的範圍。視訊支氣管鏡允許醫療保健專業人員進行遠端諮詢並與專家合作。遠端醫療使偏遠和服務欠缺地區的患者能夠獲得醫療保健服務,包括支氣管鏡檢查和後續護理,而無需遠距前往醫療機構。遠端醫療允許醫療保健提供者遠距與患者進行諮詢。您可以與專家共用您的支氣管鏡檢查觀察、圖像和影片,以進行評估和建議,這樣無論您身在何處,都可以聽到他們的意見。遠端醫療和遠距醫療保健服務的成長正在對市場產生重大影響。
市場抑制因素
感染風險高
支氣管鏡手術有感染疾病的風險。確保支氣管鏡的正確清洗、消毒和滅菌對於預防醫療相關感染至關重要。支氣管鏡是複雜的醫療設備,具有多個通道和組件,使得徹底清洗變得困難。包括微生物生物膜在內的污染物可能隱藏在縫隙和通道中,增加感染傳播的風險。清洗和再處理支氣管鏡時的人為錯誤是一個嚴重的問題。手動清洗、消毒和滅菌錯誤可能會留下持有傳染性病原體的污染物。因此,感染叢集和爆發的檢測可能會被延遲。與支氣管鏡檢查相關的感染傳播風險是醫療保健產業和市場的重大課題。
依類型分類的展望
內視鏡市場分為剛性型和軟性型。 2022 年,光纖領域在市場中佔了重要的收益佔有率。軟性支氣管鏡直徑較小,侵入性較小,可減少患者在手術過程中的不適和焦慮。軟性支氣管鏡用途廣泛,可用於各種診斷和治療過程。適合觀察整個氣道,包括支氣管和周圍氣道。由於其彈性,軟性內視鏡很容易在氣道內操縱和導航。軟性支氣管鏡的優點包括患者友善設計、多功能性、先進的影像處理功能以及適合各種診斷和治療應用。支氣管鏡檢查已成為呼吸醫學的標準工具,在肺部和氣道疾病的診斷和治療中發揮重要作用。
靈活的前景
在軟性類型中,市場分為視訊、光纖和混合。在2022年的市場中,光纖領域獲得了可觀的收益佔有率。纖維支氣管鏡檢查通常用於診斷目的。醫療保健提供者可以檢查支氣管樹並檢測腫瘤、感染、外來物和發炎等異常情況。光纖束提供的光學清晰度可實現精確的可視化。纖維支氣管鏡檢查用於檢查氣道、評估氣道通暢性並識別阻塞和病變。它是評估患有咳嗽、咯血和喘息等呼吸道症狀的患者的寶貴工具。纖維支氣管鏡用於定位和清除氣道中的異物,例如食物顆粒或吸入物。支氣管鏡的彈性和可操作性有助於提高這些手術的準確性。
依用途分類的展望
依應用分類,市場分為可重複使用型和一次性型。到 2022 年,一次性區隔市場將佔重要的市場收益佔有率佔有率。一次性支氣管鏡是在受控條件下製造的,確保每個範圍都是最佳的。這種一致性對於影像品質和功能至關重要的關鍵程序尤其重要。醫療保健提供者發現一次性支氣管鏡很方便,因為它們不需要設定、校準或滅菌並且可以立即使用。這在緊急情況下尤其有利。一次性支氣管鏡適用於使用後處理設施有限或不切實際的偏遠或現場位置。
最終用途展望
根據最終用途,市場分為醫院和門診設施。 2022年,醫院區隔市場收益佔有率最大。醫院使用支氣管鏡進行診斷。將支氣管鏡插入患者氣道以觀察氣管、支氣管和支氣管。這使我們能夠識別腫瘤、感染、發炎和出血等異常情況。也可以使用支氣管鏡從氣道採集組織樣本,並將其送到病理部門進行分析。在醫院,支氣管鏡用於治療目的。它用於給藥、進行支氣管熱成形術以治療氣喘以及治療咳血(吐血)和狹窄(氣道變窄)等疾病。
區域展望
依地區分類,對北美、歐洲、亞太地區和拉丁美洲地區市場進行了分析。 2022年,北美地區以最高的收益佔有率引領市場。該地區先進的醫療基礎設施允許引進最新的醫療技術和醫療設備,包括支氣管鏡檢查。優質的醫療設施和熟練的勞動力正在促進市場的成長。北美是醫療創新中心。該地區的製造商繼續開發和引進先進的支氣管鏡技術,包括提供更高畫質晰度影像、改進的可操作性以及與數位系統整合的數位位視訊支氣管鏡。
The Global Bronchoscopes Market size is expected to reach $4.4 billion by 2030, rising at a market growth of 6.9% CAGR during the forecast period. In the year 2022, the market attained a volume of 1,308.1 thousand units, experiencing a growth of 9.6% (2019-2022).
Video bronchoscopes have high-resolution cameras and advanced imaging technologies, such as high-definition (HD) and 4K video capabilities. Hence, video segment would acquire approximately 1/2th share in the Flexible segment of the market by 2030. These technologies provide clear and detailed images of the respiratory tract, allowing healthcare professionals to visualize and assess the airway more effectively. Video bronchoscopes offer real-time visualization of the airway during procedures. This real-time feedback is crucial for diagnosing conditions, guiding interventions, and ensuring patient safety. Video bronchoscopes allow healthcare providers to document procedures by recording video and capturing images. This documentation can be used for patient records, education, and consultation with colleagues, contributing to improved patient care.
The major strategies followed by the market participants are Product Launches as the key developmental strategy to keep pace with the changing demands of end users. For instance, In January, 2023, Fujifilm Holdings Corporation unveiled PB2020-M2, an ultrasonic probe system for enhanced examination. The probe has an outer diameter range of 1.4-1.9mm and is compatible with a 2mm working channel bronchoscope. In November, 2022, Fujifilm Holdings Corporation introduced EB-710P, a slim video bronchoscope. The EB-710P comes with a compact CMOS sensor and a 4.1 mm tip diameter.
Based on the Analysis presented in the KBV Cardinal matrix; Johnson & Johnson is the forerunner in the Market. Companies such as Medtronic PLC, Fujifilm Holdings Corporation, Olympus Corporation are some of the key innovators in the Market. In July, 2022, Medtronic PLC announced the launch of ILLUMISITE, a system used for bronchoscopic procedures. The system offers several benefits including minimally invasive facility, better visibility for tissue abnormality, expanded access for lesions, etc.
COVID-19 Impact Analysis
The respiratory system was the system that COVID-19 most affected, which caused a spike in demand for bronchoscopes and other diagnostic tools for the respiratory system. Hospitals and healthcare facilities needed bronchoscopes to diagnose and treat COVID-19 patients, especially those with severe respiratory symptoms. Many healthcare facilities had to reallocate resources and prioritize COVID-19-related care and equipment. The pandemic accelerated research and development efforts in the healthcare sector, including developing new medical devices and technologies. This led to innovations in bronchoscope design and functionality. Infection control measures became a top priority in healthcare settings. Manufacturers and healthcare providers implemented enhanced sterilization and cleaning protocols for bronchoscopes to reduce the risk of cross-contamination. Therefore, COVID-19 pandemic had a moderate effect on the market.
Market Growth Factors
Rising prevalence of respiratory diseases
The increasing incidence of respiratory diseases such as lung cancer, chronic obstructive pulmonary disease (COPD), asthma, and pneumonia has driven the demand for bronchoscopic procedures for diagnosis and treatment. Lung cancer is one of the leading causes of cancer-related deaths globally. It often requires bronchoscopic procedures for diagnosis, staging, and treatment planning. Early detection and accurate diagnosis through bronchoscopy are critical for improving survival rates. COPD comprises conditions including chronic bronchitis and emphysema. It assess airway inflammation, collect tissue samples for diagnosis, and provide therapeutic interventions to manage symptoms and improve lung function. The rising prevalence of respiratory diseases is a significant driver of growth in the market.
Growing adoption of telemedicine and remote consultations
The growth of telemedicine and remote healthcare services has expanded the reach of bronchoscopic procedures. Video bronchoscopes enable healthcare professionals to conduct remote consultations and collaborate with specialists. Telemedicine authorizes patients in remote or underserved areas to access healthcare services, including bronchoscopic consultations and follow-up care, without traveling long distances to a healthcare facility. Telemedicine enables healthcare providers to conduct remote consultations with patients. Bronchoscopic findings, images, and videos can be shared with specialists for evaluation and recommendations, allowing expert input regardless of geographical location. The growth of telemedicine and remote healthcare services has significantly impacted the market.
Market Restraining Factors
Higher risk of infection transmission
Bronchoscopic procedures carry the risk of infection transmission. Ensuring proper cleaning, disinfection, and sterilization of bronchoscopes is crucial to prevent healthcare-associated infections. Bronchoscopes are intricate medical devices with multiple channels and components, which makes them challenging to clean thoroughly. Contaminants, including microbial biofilms, can hide in crevices and channels, increasing the risk of infection transmission. Human error during the cleaning and reprocessing of bronchoscopes is a significant concern. Manual cleaning, disinfection, or sterilization errors can leave behind contaminants that harbour infectious agents. This can result in delayed recognition of infection clusters or outbreaks. The risk of infection transmission associated with bronchoscopes presents a significant challenge in the healthcare industry and the market.
Type Outlook
Based on type, the market is classified into rigid and flexible. The fiberoptic segment garnered a significant revenue share in the market in 2022. Flexible bronchoscopes have a smaller diameter and are less invasive, which can reduce patient discomfort and anxiety during the procedure. Flexible bronchoscopes are highly versatile and can be used for various diagnostic and therapeutic procedures. They are suitable for visualizing the entire respiratory tract, including the bronchi and peripheral airways. Flexible bronchoscopes are easier to maneuver and navigate through the airways due to their flexibility. The advantages of flexible bronchoscopes include their patient-friendly design, versatility, advanced imaging capabilities, and suitability for various diagnostic and therapeutic applications. They have become a standard tool in respiratory medicine and play a significant role in diagnosing and treating lung and airway disorders.
Flexible Outlook
Under flexible type, the market is divided into video, fiberoptic, and hybrid. The fiberoptic segment garnered a significant revenue share in the market in 2022. Fiberoptic bronchoscopes are commonly used for diagnostic purposes. They allow healthcare providers to examine the bronchial tree and detect abnormalities like tumours, infections, foreign bodies, and inflammation. The optical clarity provided by fiberoptic bundles enables precise visualization. Fiberoptic bronchoscopes are used to inspect the airway, assess airway patency, and identify any obstructions or lesions. They are valuable tools for evaluating patients with respiratory symptoms, including cough, hemoptysis, and wheezing. Fiberoptic bronchoscopes are used to locate and remove foreign objects, such as food particles or inhaled objects, from the airway. Their flexibility and maneuverability aid in precision during these procedures.
Usage Outlook
By usage, the market is categorized into reusable and disposable. The disposable segment covered a considerable revenue share in the market in 2022. Disposable bronchoscopes are manufactured under controlled conditions, ensuring that each scope is optimal. This consistency can be especially important for critical procedures where image quality and functionality are essential. Healthcare providers find disposable bronchoscopes convenient because they can be used immediately without the need for setup, calibration, or sterilization. This can be particularly advantageous in emergencies. Disposable bronchoscopes are well-suited for use in remote or field settings where access to reprocessing facilities is limited or impractical.
End Use Outlook
On the basis of end-use, the market is segmented into hospitals and outpatient facilities. In 2022, the hospitals segment registered the maximum revenue share in the market. Hospitals use bronchoscopes for diagnostic purposes. These procedures involve the insertion of the bronchoscope into the patient's airways to visualize the trachea, bronchi, and bronchioles. This helps identify abnormalities like tumours, infections, inflammation, and bleeding. It enables the collection of tissue samples from the airways, which are then sent to the pathology department for analysis. Hospitals utilize bronchoscopes for therapeutic purposes. They can be used to deliver medications, perform bronchial thermoplasty for asthma management, or treat conditions like hemoptysis (coughing up blood) or strictures (narrowing of airways).
Regional Outlook
Region-wise, the market is analysed across North America, Europe, Asia Pacific, and LAMEA. In 2022, the North America region led the market by generating the highest revenue share. The region's advanced healthcare infrastructure enables the adoption of the latest medical technologies and devices, including bronchoscopes. High-quality healthcare facilities and a skilled workforce contribute to the market's growth. North America is a hub for medical technology innovation. Manufacturers in the region continually develop and introduce advanced bronchoscope technologies, such as digital video bronchoscopes with high-definition imaging, enhanced manoeuvrability, and integration with digital systems.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Teleflex, Inc., Olympus Corporation, Ambu A/S, Karl Storz SE & Co. KG, Fujifilm Holdings Corporation, Boston Scientific Corporation, Cook Medical, Inc. (Cook Group), Medtronic PLC, Johnson & Johnson, Richard Wolf GmbH (The Richard and Annemarie Wolf Foundation)
Recent Strategies Deployed in Bronchoscopes Market
Product Launches and Product Expansions:
Jan-2023: Fujifilm Holdings Corporation unveiled PB2020-M2, an ultrasonic probe system for enhanced examination. The probe has an outer diameter range of 1.4-1.9mm and is compatible with a 2mm working channel bronchoscope.
Nov-2022: Fujifilm Holdings Corporation introduced EB-710P, a slim video bronchoscope. The EB-710P comes with a compact CMOS sensor and a 4.1 mm tip diameter. Additionally, it has a teardrop-shaped dial which facilitates smooth handling during procedures.
Jul-2022: Medtronic PLC announced the launch of ILLUMISITE, a system used for bronchoscopic procedures. The system offers several benefits including minimally invasive facility, better visibility for tissue abnormality, expanded access for lesions, etc.
Apr-2021: Olympus Corporation announced the launch of H-SteriScope Single-Use Bronchoscopes, a series of five single-use endoscopes used for diagnostic and therapeutic procedures. The bronchoscopes feature an outer diameter range of 2.2 to 6.2 mm and working channels that span 1.2 to 3.2 mm. Additionally, the bronchopes have a rotary function for east positioning and Tip Angulation for easy target access.
Mergers & Acquisition:
Sep-2021: Boston Scientific Corporation took over the international surgical business of Lumenis, a medical device manufacturer based in Israel. The acquisition complements Boston Scientific's kidney stone management portfolio and expands its presence in Europe and Asia.
Jun-2021: Boston Scientific Corporation announced the acquisition of Farapulse Inc., a medical device manufacturing company. The acquisition complements and strengthens Boston Scientific's electrophysiology portfolio.
Partnerships, Collaborations & Agreements:
Apr-2023: Fujifilm Holdings Corporation partnered with Tata Memorial Center, an Indian cancer research institute, to establish a training facility in the Tata Memorial Center. The partnership comes in line with Fujifilm's aim to improve healthcare in the Indian market.
Trials and Approvals:
Jul-2022: Ambu A/S received approval from the US FDA for its Ambu aScopeTM 5 Broncho, a series of single-use sterile bronchoscopes.
Aug-2021: Boston Scientific Corporation announced the US FDA approval for its announced U.S. Food and Drug Administration (FDA) 510(k) clearance of the EXALT Model B Single-Use Bronchoscope. The EXALT Model B Bronchoscope is used for a variety of bronchoscopy procedures including secretion management, percutaneous tracheostomy, airway intubation, etc.
Market Segments covered in the Report:
By Type (Volume, Thousand Units, USD Billion/Million, 2019-2030)
By Usage (Volume, Thousand Units, USD Billion/Million, 2019-2030)
By End Use (Volume, Thousand Units, USD Billion/Million, 2019-2030)
By Geography (Volume, Thousand Units, USD Billion/Million, 2019-2030)
Companies Profiled
Unique Offerings from KBV Research